Skip to content

Clinical trials

Carcinoma, Merkel Cell trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Carcinoma, Merkel Cell Clear all

147 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20021
20031
20042
20081
20092
20102
20122
20133
20145
20157
20166
201713
201810
201915
202013
202114
202210
202313
20246
20258
20266

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed45
Recruiting31
Terminated29
Active, not recruiting24
Withdrawn6
Not yet recruiting5
Unknown status5
Available1
Approved for marketing1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
National Cancer Institute (NCI)10
Memorial Sloan Kettering Cancer Center5
Fate Therapeutics4
Fred Hutchinson Cancer Center4
H. Lee Moffitt Cancer Center and Research Institute4
ImmunityBio, Inc.4
Incyte Biosciences International Sàrl4
Incyte Corporation4
TuHURA Biosciences, Inc.4
M.D. Anderson Cancer Center3

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Carcinoma, Merkel Cell147
Melanoma61
Carcinoma, Non-Small-Cell Lung37
Carcinoma, Renal Cell36
Uterine Cervical Neoplasms30
Small Cell Lung Carcinoma28
Stomach Neoplasms28
Carcinoma, Hepatocellular25
Carcinoma, Transitional Cell25
Squamous Cell Carcinoma of Head and Neck23

Trials

Showing 51 to 75 of 147. Each trial links to its page on Pharma Observatory.

47 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.